BR0209864A - Composição de galato de epigalocatequina - Google Patents

Composição de galato de epigalocatequina

Info

Publication number
BR0209864A
BR0209864A BR0209864-4A BR0209864A BR0209864A BR 0209864 A BR0209864 A BR 0209864A BR 0209864 A BR0209864 A BR 0209864A BR 0209864 A BR0209864 A BR 0209864A
Authority
BR
Brazil
Prior art keywords
epigallocatechin gallate
gallate composition
composition
egcg
granulate
Prior art date
Application number
BR0209864-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Chyi-Cheng Chen
Bruno Leuenberger
Original Assignee
Roche Vitamins Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8178165&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0209864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Vitamins Ag filed Critical Roche Vitamins Ag
Publication of BR0209864A publication Critical patent/BR0209864A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fertilizers (AREA)
BR0209864-4A 2001-07-30 2002-07-22 Composição de galato de epigalocatequina BR0209864A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01118246 2001-07-30
PCT/EP2002/008127 WO2003011339A1 (en) 2001-07-30 2002-07-22 Composition for epigallocatechin gallate

Publications (1)

Publication Number Publication Date
BR0209864A true BR0209864A (pt) 2004-06-08

Family

ID=8178165

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209864-4A BR0209864A (pt) 2001-07-30 2002-07-22 Composição de galato de epigalocatequina

Country Status (13)

Country Link
US (1) US20040198673A1 (https=)
EP (1) EP1411986B1 (https=)
JP (1) JP2005501833A (https=)
KR (1) KR100611855B1 (https=)
CN (2) CN1325049C (https=)
AT (1) ATE388723T1 (https=)
AU (1) AU2002327893B8 (https=)
BR (1) BR0209864A (https=)
CA (1) CA2450772C (https=)
DE (1) DE60225560T2 (https=)
ES (1) ES2301670T3 (https=)
MX (1) MXPA04000618A (https=)
WO (1) WO2003011339A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE480233T1 (de) * 2005-02-15 2010-09-15 Dsm Ip Assets Bv Zusammensetzungen mit polysacchariden
CN100446762C (zh) * 2005-09-05 2008-12-31 中山大学 （-）-表没食子儿茶素没食子酸酯固体分散体及其制备方法与应用
WO2009056212A1 (en) * 2007-10-29 2009-05-07 Dsm Ip Assets B.V. Compositions containing resveratrol and pectin
ES2694426T3 (es) 2012-10-04 2018-12-20 Abbott Laboratories Procedimientos para mejorar el efecto de EGCg en la mitigación de la pérdida de músculo esquelético
WO2015136551A2 (en) * 2014-03-12 2015-09-17 Tata Chemicals Limited A molecular complex of epigallocatechin-3-gallate and a process for production thereof
CN104719910B (zh) * 2015-04-19 2017-07-28 福州乾正药业有限公司 具有热稳定性的egcg固体分散体组合物及其制备方法和应用
CN113384781B (zh) * 2020-03-11 2024-03-29 李彤 一种egcg雾化系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666484A (en) * 1969-11-12 1972-05-30 Lipton Inc Thomas J Process for making a spray-dried instant tea of desired bulk density
US4268533A (en) * 1979-11-21 1981-05-19 General Foods Corporation Quick-set low methoxyl pectin composition
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof
US4800096A (en) * 1987-05-29 1989-01-24 General Foods Corporation Pectin gelling composition
JP2812682B2 (ja) * 1988-05-24 1998-10-22 株式会社伊藤園 コレステロール排泄促進剤及びコレステロール排泄促進飲食物
DE3903217A1 (de) * 1989-02-03 1990-08-09 Boehringer Ingelheim Vetmed Verfahren zur herstellung fester pharmazeutischer zubereitungen
JPH03141220A (ja) * 1989-10-26 1991-06-17 Tsumura & Co 抗レトロウイルス剤
US4935256A (en) * 1989-10-31 1990-06-19 Procter & Gamble Company Process for making green tea solids
PT96229B (pt) * 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
JPH0595988A (ja) * 1990-10-22 1993-04-20 Kanebo Ltd 漢方エキス造粒物および漢方エキス含有固形製剤の製造方法
JPH04253918A (ja) * 1991-02-05 1992-09-09 Mitsui Norin Kk 血糖上昇抑制剤
JP3469258B2 (ja) * 1992-10-09 2003-11-25 太陽化学株式会社 腎機能改善用剤
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
JPH07223941A (ja) * 1994-02-14 1995-08-22 Nippon Ham Kk 抗補体作用物質
JP4127864B2 (ja) * 1994-09-29 2008-07-30 太陽化学株式会社 グラム陰性菌増殖抑制剤
JPH08253423A (ja) * 1995-01-19 1996-10-01 Tokushu Meneki Kenkyusho:Kk ラクトフェリン含有食品・医薬品顆粒およびその製造 方法
CA2175985A1 (en) * 1995-05-10 1996-11-11 Yoichi Kiyosuke Pharmaceutical composition containing substance inhibiting hsp47 production
US5997937A (en) * 1996-05-06 1999-12-07 Kraft Foods, Inc. Quick-setting gel mix
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
JP4098376B2 (ja) * 1996-09-05 2008-06-11 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤特性の優れた水溶性ビタミン組成物およびその製造法
US6077543A (en) * 1996-12-31 2000-06-20 Inhale Therapeutic Systems Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
JPH10279486A (ja) * 1997-04-02 1998-10-20 Taiyo Kagaku Co Ltd 免疫賦活組成物
JPH11116475A (ja) * 1997-10-07 1999-04-27 Snow Brand Milk Prod Co Ltd 炎症性腸疾患予防及び／又は治療剤
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
US6410061B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins as cancer specific proliferation inhibitors
JP4082823B2 (ja) * 1999-05-06 2008-04-30 日本メナード化粧品株式会社 光毒性抑制剤
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
FI20000004A0 (fi) * 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke...
JP3694733B2 (ja) * 2000-06-29 2005-09-14 独立行政法人農業・生物系特定産業技術研究機構 抗アレルギー剤
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom

Also Published As

Publication number Publication date
AU2002327893B8 (en) 2007-01-18
DE60225560D1 (de) 2008-04-24
KR100611855B1 (ko) 2006-08-11
JP2005501833A (ja) 2005-01-20
ES2301670T3 (es) 2008-07-01
CN1325049C (zh) 2007-07-11
EP1411986B1 (en) 2008-03-12
WO2003011339A1 (en) 2003-02-13
CN1509186A (zh) 2004-06-30
US20040198673A1 (en) 2004-10-07
CN101028253A (zh) 2007-09-05
AU2002327893B2 (en) 2006-12-21
EP1411986A1 (en) 2004-04-28
CA2450772A1 (en) 2003-02-13
KR20040032872A (ko) 2004-04-17
ATE388723T1 (de) 2008-03-15
DE60225560T2 (de) 2009-04-02
AU2002327893A1 (en) 2003-02-17
MXPA04000618A (es) 2005-06-17
CA2450772C (en) 2008-09-30

Similar Documents

Publication Publication Date Title
ATE438638T1 (de) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
UY27346A1 (es) Composiciones farmaccuticas que contienen conjuntos de polemero y frrmaco.
DK1644348T3 (da) Epoxy-afsluttede polythioethere, Epoxy-afsluttede polythioethere
BR0108920A (pt) Sistema de comunicação via rádio e internet
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
MXPA04001785A (es) Benzofurano y derivados de dihidrobenzofurano utiles como agonistas de beta-3 adrenoreceptores.
DE50012008D1 (de) Zementzusammensetzungen, enthaltend redispergierbare Polymerisatpulver
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
AU2003293592A1 (en) Novel nutraceutical compositions comprising epigallocatechin gallate
BR0305767A (pt) Métodos e composições para a preparação de derivados de ácido 4-substituìdo 3-hidroxibutìrico
ECSP044981A (es) Composicion oftalmica que comprende ascomicina
DK1536783T3 (da) Faste formuleringer, der omfatter en indolinonforbindelse
ATE416629T1 (de) Antioxidative zusammensetzungen
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
BR0209864A (pt) Composição de galato de epigalocatequina
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
AU2002357184A1 (en) SUBSTITUTED 6H-DIBENZO(c,h)CHROMENES AS ESTROGENIC AGENTS
PT1204659E (pt) Benzofuranos serotoninergicos
BRPI0417205A (pt) composições farmacêuticas
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
JP2005501833A5 (https=)
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
IT1317841B1 (it) Derivati del 3,9-diazabiciclo(3.3.1)nonano ad attivita' analgesica.
ID27733A (id) Metoksiminofenilasetamida

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: DSM IP ASSETS B.V. (NL)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.